TABLE 5.
TraM Plasmid | β-Galactosidase sp act (Miller units)b with:
|
|||
---|---|---|---|---|
No inducer | AAIc | IPTG (1 mM) | IPTG + AAI | |
pBBR1-MCS5 (vector)d | <5 | 571 | <5 | 551 |
pGB200 (Ti traM) | <5 | 528 | <5 | 32 |
pCF424 (NGR234 traM) | <5 | 578 | <5 | 612 |
All assays were performed with A. tumefaciens NTL4 harboring pCF218 (PtetR-traR) and pCF372 (PtraI-lacZ).
Results are averages from assays in triplicate.
With 0.05% (vol/vol) cell-free supernatant of the AAI overproducer A. tumefaciens KYC6(pCF218), having bioactivity equivalent to 0.4 μM synthetic 3-oxo-C8-HSL.
Both traM expression plasmids are derivatives of pBBR1-MCS5.